Atlas Trials

Open Label Extension Study of Bifeprunox

Clinical trial NCT00366171 · COMPLETED

Trial details

NCT number
NCT00366171
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Schizophrenia
Start date
2006-11-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.